IPSC — Century Therapeutics Balance Sheet
0.000.00%
- $211.25m
- $19.24m
- $2.24m
- 21
- 13
- 35
- 12
Annual balance sheet for Century Therapeutics, fiscal year end - December 31st, millions except per share.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | PROSPECTUS | 10-K | 10-K | 10-K | |
Standards: | — | USG | USG | USG | USG |
Status: | fx Preliminary | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | — | 75.8 | 223 | 315 | 173 |
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | — | 78.8 | 228 | 320 | 177 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | — | 24.8 | 69.8 | 112 | 92.1 |
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | — | 107 | 437 | 487 | 361 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | — | 12.1 | 15.7 | 29.8 | 17.8 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | — | 33.4 | 41.1 | 184 | 176 |
Non Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | — | 73.3 | 396 | 303 | 185 |
Total Liabilities & Shareholders' Equity | — | 107 | 437 | 487 | 361 |
Total Common Shares Outstanding |